Association of demographic characteristics among 727 surveyed rheumatologists with the decision to prescribe PCP prophylaxis.
| Demographic Characteristic | Prescribe PCP Prophylaxis n (%)* | Univariate Logistic Regression | Multivariate Logistic Regression | ||
|---|---|---|---|---|---|
| OR (95% CI) | p | OR (95% CI) | p | ||
| Female | 191 (74.9) | 1.47 (1.04, 2.08) | 0.03 | 1.01 (0.68, 1.50) | 0.97 |
| Male | 308 (67.0) | ||||
| US-based practice | 420 (72.0) | 1.77 (1.20, 2.61) | 0.004 | 1.97 (1.27, 3.05) | 0.003 |
| Internationally based practice | 80 (59.2) | ||||
| Acedemic practice | 248 (81.0) | 2.75 (1.94, 3.89) | < 0.001 | 1.81 (1.23, 2.66) | 0.003 |
| Nonacademic practice | 252 (60.9) | ||||
| ≤ 10 years in practice | 206 (86.6) | 4.08 (2.69, 6.18) | < 0.001 | 4.13 (2.62, 6.51) | < 0.001 |
| > 10 years in practice | 292 (61.2) | ||||
| ≥ 10% patients on chronic glucocorticoids | 414 (72.8) | 2.04 (1.40, 2.96) | < 0.001 | 2.11 (1.38, 3.23) | 0.001 |
| < 10% patients on chronic glucocorticoids | 84 (56.8) | ||||
| ≥ 10% patients on other immunosuppressants | 488 (70.5) | 3.19 (1.48, 6.86) | 0.003 | 2.26 (0.98, 5.26) | 0.06 |
| < 10% patients on other immunosuppresants | 12 (42.8) | ||||
| Caring previously for a patient who developed PCP | 159 (82.8) | 2.62 (1.73, 3.98) | < 0.001 | 3.04 (1.92, 4.82) | < 0.001 |
| Never caring for a patient who developed PCP | 345 (64.7) | ||||
| ≤ 10 patients with rheumatologic diagnosis under clinical care each week | 43 (76.8) | 1.48 (0.78, 2.82) | 0.23 | —** | — |
| > 10 patients with rheumatologic diagnosis under clinical care each week | 455 (69) | ||||
↵* Among survey respondents, the proportion with each characteristic who reported prescribing PCP prophylaxis.
↵** Number of patients with a rheumatologic diagnosis was not included in the final multivariate analysis because this variable did not achieve statistical significance in the univariate analysis.